LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Hummel, S.R.; Sadler, S.; Whitaker, M.J.; Ara, R.M.; Dixon, S.; Ross, R.J. (2016)
Publisher: Wiley
Languages: English
Types: Article
Subjects:

Classified by OpenAIRE into

mesheuropmc: endocrine system diseases
Aim Patients with classic congenital adrenal hyperplasia (CAH)have poor health outcomes. In the absence of a comprehensive observational study, this manuscript provides a model to esti-mate the lifetime disease burden of adults with classic CAH. Methods The model, built in Excel, comprises subdomains addressing the health consequences of CAH and synthesises evidence from clinical and epidemiological studies on health out-comes.Results The model estimates that adults with classic CAH will implement ‘sick day rules’ (doubling or tripling glucocorticoid and/or use of parenteral therapy) 171 times over their lifetime and attend hospital for adrenal crisis on 11 occasions. In a population of 1000, over 200 will die of a condition complicated by adrenal crisis resulting, on average, in a loss of 7 years of life.Patients with CAH may also suffer from excess CVD events.Treatment with glucocorticoids almost doubles the risk of bone fractures in patients with CAH compared to the general popula-tion, leading on average to an additional 08 fractures perpatient with CAH over their lifetime.Conclusions The disease burden model highlights gaps in evidence, particularly regarding intensity of care and adrenal crisis,and the relationship between control of CAH and risks of CVD, osteoporosis, diabetes and infertility. The model can be used for research on the impact of new clinical pathways and therapeutic interventions in terms of clinical events and cost.

Share - Bookmark

Funded by projects

  • EC | TAIN

Cite this article